Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03621787 · ClinicalTrials.gov registry record · NA
Assessing the Safety and Efficacy of a Novel Subcutaneous Implant Insertion Device on Healthy Adults
A NA study, sponsored by University of Michigan.
- Terminated
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT03621787: Clinical Trial NA study, sponsored by University of Michigan.
NCT03621787 is a NA study that was terminated before completion, run by University of Michigan. The registered enrollment target is 9 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03621787, a NA study, was terminated before completion, sponsored by University of Michigan.
- TERMINATED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
The investigators have created a device designed to make it easier to insert pharmaceutical implants under the skin. The device uses a blood pressure cuff to hold the skin on a person's arm in place while a mechanical guide places implants underneath the skin. This device may prevent implants from being embedded too deeply. The investigators are performing this study to determine the safety and efficacy of the device for use in adult women. The study will determine if the implants are placed accurately under the skin (in the sub-dermal layer). It will also assess if the device causes any discomfort or last pain from use.
Primary Outcome
Depth of distal end of implant beneath the skin after insertion. Measured via high frequency ultrasound with linear probe. Measured in centimeters below skin surface. Measurements will be aggregated via mean and standard deviation.
Interventions
- DEVICE Implant insertion device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2018-11-08 |
| Est. Completion | 2019-12-01 |
| Phase | NA |
Why NCT03621787 stopped before completion
NCT03621787 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Implant insertion device is the first listed.
NCT03621787 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03621787 about?
NCT03621787 is a clinical study titled "Assessing the Safety and Efficacy of a Novel Subcutaneous Implant Insertion Device on Healthy Adults". The investigators have created a device designed to make it easier to insert pharmaceutical implants under the skin. The device uses a blood pressure cuff to hold the skin on a person's arm in place while a mechanical guide places implants underneath the skin. This device may prevent implants from b...
What is the current status of trial NCT03621787?
This trial is currently terminated. It is a NA study. The enrollment target is 9 participants. The study started on 2018-11-08. Estimated completion is 2019-12-01.
What interventions are being tested in trial NCT03621787?
The interventions under investigation include: Implant insertion device (DEVICE).
Who is sponsoring clinical trial NCT03621787?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03621787's enrollment target sits among peer trials
9 1975th of 2000 higher than 25 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI